Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.
Morning Overview on MSN
A gut-heart link may explain why sleep apnea quietly raises heart-disease risk
People with obstructive sleep apnea face elevated rates of coronary heart disease and cardiovascular death, yet treating the ...
A deeper look at what one supercentenarian’s labs can teach us about aging, cholesterol, and what really matters for ...
A newly developed framework for understanding the photoproperties of both natural organic matter and eumelanin, a natural pigment responsible for dark colors in organisms, may inspire advanced ...
A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results